Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-07-24
2007-07-24
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007100
Reexamination Certificate
active
11154435
ABSTRACT:
Sixteen membered macrolide anti-infective agents having a structure according to formula Iwhere R1, R2, R3, R4, R5, and R6are as defined herein, and related compounds are disclosed.
REFERENCES:
patent: 3459853 (1969-08-01), Gorman et al.
patent: 3784447 (1974-01-01), Theriault
patent: 4321361 (1982-03-01), Baltz et al.
patent: 4918058 (1990-04-01), Lukacs et al.
patent: 5023240 (1991-06-01), Narandja et al.
patent: 5140014 (1992-08-01), Maring et al.
patent: 5545624 (1996-08-01), Hecker et al.
patent: 5677287 (1997-10-01), Jaynes
patent: 5688924 (1997-11-01), Narandja et al.
patent: 5922684 (1999-07-01), Narandja et al.
patent: 6680299 (2004-01-01), Or et al.
patent: 2002/0128213 (2002-09-01), Katz et al.
patent: 2004/0014687 (2004-01-01), Ma et al.
patent: 0070170 (1983-01-01), None
patent: 0287082 (1987-04-01), None
patent: 0410433 (1991-01-01), None
patent: 0985679 (2000-03-01), None
patent: 62-221695 (1987-09-01), None
patent: WO 2005/118610 (2005-12-01), None
Debono et al., J. Antibiotics 42 (8), 1253-1267 (1989), “Synthesis and Antimicrobial Evaluation of 20-Deoxo-20-(3,5-dimethylpiperidin-1-ylo)desmycosin (Tilmicosin, EL-870) and Related Cyclic Amino Derivatives”.
Grandjean et al., J. Carbohydrate Chem. 15 (7), 831-855 (1996), “SN2 Displacement of Carbohydrate Triflates by 9-Oximes of Erythromycin A and of a Tylosin Derivative”.
Maring et al., J. Antibiotics 44 (4), 448-450 (1991), “Synthesis and Antimicrobial Activities of 9(S)-N,N-Dimethyl-amino-9-deoxo-10,11,12,13,-tetrahydroniddamycin”.
Narandja et al., J. Antibiotics 52 (1), 68-70 (1999), “New Derivatives of Tylosin IV. Dihydro and Tetrahydro Desmycosin Oximes”.
Ruggeri et al., J. Antibiotics 42 (9), 1443-1445 (1989), “Synthesis and Antibacterial Activity of 9-O-[(2-Methoxy-Demycarosyltylosin”.
Sakamoto et al., J. Antibiotics 37 (12), 1628-1634 (1984), “Synthesis of 23-Deoxy-23-N-ethyl-23-(2-fluoro-, 2,2-difluoro, and 2,2,2-trifulorethyl)amino Derivative of Myca-minosyl Tylonolide and 4′-Deoxymycaminosyl Tylonolide”.
Tanaka et al., J. Antibiotics 35 (1), 113-116 (1982), “Synthesis of 23-Dialkylamino Derivatives of Mycaminosyl Tylonolide and 4′-Deoxymycominosyl Tylonolide Effective Against Gram-Negative Bacteria”.
Wermuth, ed.,The Practice of Medicinal Chemistry, 2nd Ed., pp. 561-586 (Academic Press 2003), “Designing Prodrugs and Bioprecursors”.
Fu Hong
Katz Leonard
Myles David C.
Chao Yuan
Kosan Biosciences Incorporated
Peselev Elli
LandOfFree
Sixteen-member macrolide antiinfective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sixteen-member macrolide antiinfective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sixteen-member macrolide antiinfective agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3780378